Gregory G. Burrows
No más puestos en curso
Perfil
Gregory G.
Burrows is the founder of Artielle ImmunoTherapeutics, Inc. which was founded in 2004.
He held the title of Scientist at the company.
Burrows received his undergraduate degree from Clark University and his doctorate degree from Washington State University.
Antiguos cargos conocidos de Gregory G. Burrows.
| Empresas | Cargo | Fin |
|---|---|---|
Artielle ImmunoTherapeutics, Inc.
 Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | Fundador | 18/11/2014 |
Formación de Gregory G. Burrows.
| Clark University | Undergraduate Degree |
| Washington State University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Artielle ImmunoTherapeutics, Inc.
Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Gregory G. Burrows
